Trademark: ARIXTRA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for ARIXTRA
We do not have any records of a proof of use for ARIXTRA at this moment.
Possible trademark infringements of ARIXTRA
Basic Information about ARIXTRA
- Serial Number
- 76251409
- Filing Date
- 04 May 2001
- Registration Number
- 2725323
- Registration Date
- 10 Jun 2003
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of ARIXTRA on the blockchain with WikiTrademarks.io.
- First use of ARIXTRA anywhere
- ARIXTRA was first used on 04 Feb 2002 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
- First use of ARIXTRA anywhere
- ARIXTRA was first used on 04 Feb 2002 for the primary classification of goods and services, international, 010 (Medical Apparatus)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 010
- US Codes
- 026; 039; 044
Who owns ARIXTRA?
1. MYLAN INSTITUTIONAL INC. ROCKFORD IL
2. Glaxo Group Limited Brentford, Middlesex IL
3. Sanofi-Synthelabo 75013 Paris IL
4. Sanofi-Synthelabo 75013 Paris IL
5. Sanofi-Synthelabo 75013 Paris IL
Correspondent
- MYLAN INSTITUTIONAL INC.
- 1718 NORTHROCK COURT
- ROCKFORD, IL, , 61103
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io